SCP
ABBV icon

Steamboat Capital Partners’s AbbVie ABBV Stock Holding History

Steamboat Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,486
Closed -$3.2M – 33
2020
Q3 		$3.2M Sell
36,486
-450
-1% -$42.4K 0.52% 44
2020
Q2 		$3.63M Buy
+36,936
New +$3.25M 0.67% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steamboat Capital Partners's ABBV Position: Q4 2020 in Review

Steamboat Capital Partners sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 36,486 shares — an estimated $3.2M sold.

Steamboat Capital Partners first reported a position in ABBV in Q2 2020 and held it in 2 quarters. The position peaked at $3.63M in Q2 2020. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Steamboat Capital Partners reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Steamboat Capital Partners sold 36,486 AbbVie shares in Q4 2020, an estimated $3.2M.
  • Steamboat Capital Partners first reported a position in AbbVie in Q2 2020 and held it in 2 quarters.
  • Steamboat Capital Partners's AbbVie position peaked at $3.63M in Q2 2020.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Steamboat Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.